Fecal Nucleic Acid Test as a Complementary Standard for Cured COVID-19 Patients

查看全文 作　　者：HAN [1]Mei;ZOU Jing [2]Bo;LI [1]Huan;WEI Xiao [3]Yu;YANG [1]Song;ZHANG Hui [1]Zheng;WANG Peng [1]Sen;QIU [1]Qian;WANG Le [1]Le;CHEN Yao [1]Kai;PAN Pin [4]Liang

机构地区：[1]Chongqing Public Health Medical Center,Chongqing 400036,China;[2]Yongchuan district Centre for Disease Control and Prevention,Chongqing 402160,China;[3]Yongchuan Hospital of Chongqing Medical University,Chongqing 402160,China;[4]National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102200,China

出　　处：《Biomedical and Environmental Sciences》索引2020年第33卷第12期,共5页

基　　金：supported by the Project on Important Infectious Diseases Prevention and Control[2018ZX10734404];the National Science and Technology Major Project of China during the 13th Five-year Plan Period[2018ZX10302104]。 摘　　要：To date,no vaccine or specific antiviral treatment is yet available for COVID-19.The most effective control measures for the disease mainly depend on early diagnosis,strict patient quarantine,and close contact monitoring[1].Thus,reliable and accurate diagnostic methods play a critical role in global disease control and prevention.Reverse transcription-polymerase chain reaction(RT-PCR)assays are widely used for the laboratory diagnosis of virus-borne diseases. 关键词：DIAGNOSIS VACCINE PATIENTS

相关文献

参考文献（10）
引证文献（1）
耦合文献（571）

参考文献(10)

引证文献(1)

耦合文献(571)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Fecal Nucleic Acid Test as a Complementary Standard for Cured COVID-19 Patients

参考文献(10)

引证文献(1)

耦合文献(571)

用户提示